Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ketorolac (acuvail) (1 trial)
naloxone (narcan) (2 trials)
oxycodone (oxycontin) (1 trial)
pembrolizumab (keytruda) (1 trial)
pentamidine (pentam) (1 trial)
pomalidomide (pomalyst) (1 trial)
urea (1 trial)
vasopressin (vasostrict) (1 trial)
metronidazole (flagyl) (1 trial)
oxybutynin (ditropan) (1 trial)
rivastigmine (exelon) (1 trial)
l-tetrahydropalmatine (1 trial)
Acute Pain (Phase 2)
Diabetes Insipidus (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (10 total)
Trial APIs (12 total)